Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 09, 2024

SELL
$42.03 - $53.55 $30,934 - $39,412
-736 Reduced 9.94%
6,668 $289,000
Q4 2023

Feb 07, 2024

SELL
$43.39 - $51.63 $5,336 - $6,350
-123 Reduced 1.63%
7,404 $374,000
Q3 2023

Nov 06, 2023

SELL
$38.5 - $47.13 $17,941 - $21,962
-466 Reduced 5.83%
7,527 $341,000
Q2 2023

Aug 08, 2023

SELL
$34.73 - $43.33 $23,616 - $29,464
-680 Reduced 7.84%
7,993 $327,000
Q1 2023

May 08, 2023

BUY
$33.58 - $41.2 $5,842 - $7,168
174 Added 2.05%
8,673 $309,000
Q4 2022

Feb 06, 2023

SELL
$37.12 - $46.52 $12,398 - $15,537
-334 Reduced 3.78%
8,499 $321,000
Q3 2022

Nov 14, 2022

SELL
$36.54 - $48.66 $26,235 - $34,937
-718 Reduced 7.52%
8,833 $391,000
Q2 2022

Aug 05, 2022

SELL
$31.71 - $43.0 $5,168 - $7,009
-163 Reduced 1.68%
9,551 $354,000
Q1 2022

May 10, 2022

BUY
$29.88 - $37.04 $41,712 - $51,707
1,396 Added 16.78%
9,714 $360,000
Q4 2021

Feb 07, 2022

SELL
$25.61 - $35.1 $51,373 - $70,410
-2,006 Reduced 19.43%
8,318 $253,000
Q3 2021

Nov 10, 2021

SELL
$33.54 - $40.55 $8,686 - $10,502
-259 Reduced 2.45%
10,324 $346,000
Q2 2021

Aug 04, 2021

BUY
$34.54 - $47.25 $2,452 - $3,354
71 Added 0.68%
10,583 $422,000
Q1 2021

May 10, 2021

SELL
$42.51 - $63.78 $1,572 - $2,359
-37 Reduced 0.35%
10,512 $473,000
Q4 2020

Feb 08, 2021

SELL
$45.3 - $60.27 $25,005 - $33,269
-552 Reduced 4.97%
10,549 $596,000
Q3 2020

Nov 12, 2020

SELL
$47.45 - $62.95 $12,526 - $16,618
-264 Reduced 2.32%
11,101 $527,000
Q2 2020

Aug 11, 2020

SELL
$46.85 - $61.05 $57,016 - $74,297
-1,217 Reduced 9.67%
11,365 $670,000
Q1 2020

May 08, 2020

SELL
$41.6 - $63.4 $93,433 - $142,396
-2,246 Reduced 15.15%
12,582 $595,000
Q4 2019

Feb 11, 2020

SELL
$53.85 - $65.27 $52,234 - $63,311
-970 Reduced 6.14%
14,828 $896,000
Q3 2019

Nov 12, 2019

SELL
$59.06 - $72.15 $31,892 - $38,961
-540 Reduced 3.31%
15,798 $946,000
Q2 2019

Jul 31, 2019

BUY
$62.09 - $86.14 $15,832 - $21,965
255 Added 1.59%
16,338 $1.05 Million
Q1 2019

May 06, 2019

SELL
$52.92 - $81.17 $21,326 - $32,711
-403 Reduced 2.44%
16,083 $1.31 Million
Q4 2018

Feb 13, 2019

SELL
$43.37 - $59.54 $15,656 - $21,493
-361 Reduced 2.14%
16,486 $891,000
Q3 2018

Nov 13, 2018

BUY
$42.88 - $53.7 $1,715 - $2,148
40 Added 0.24%
16,847 $869,000
Q2 2018

Aug 03, 2018

SELL
$40.53 - $50.7 $42,678 - $53,387
-1,053 Reduced 5.9%
16,807 $700,000
Q1 2018

May 03, 2018

BUY
$44.08 - $55.05 $7,581 - $9,468
172 Added 0.97%
17,860 $787,000
Q4 2017

Feb 02, 2018

SELL
$50.3 - $64.39 $34,707 - $44,429
-690 Reduced 3.75%
17,688 $890,000
Q3 2017

Nov 03, 2017

BUY
$45.56 - $59.57 $837,301 - $1.09 Million
18,378
18,378 $932,000

Others Institutions Holding IONS

About IONIS PHARMACEUTICALS INC


  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $5.16B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Wrapmanager Inc Portfolio

Follow Wrapmanager Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wrapmanager Inc, based on Form 13F filings with the SEC.

News

Stay updated on Wrapmanager Inc with notifications on news.